Received: 18 December 2019
Accepted: 19 January 2021
First Online: 24 February 2021
Ethics approval and consent to participate
: Written informed consent authorizing the use of de-identified GWAS data was obtained from all subjects. The Institutional Review Board at The Children’s Hospital of Philadelphia approved the study. Written informed consent to participate in this study was obtained from the parents or legal guardians of any participant under the age of 16 with verbal assent from the participant. No administrative permissions and/or licenses were necessary to be acquired by our team to access the clinical/personal patient data used in our research.The Institutional Review Board of The Children’s Hospital of Philadelphia approved this study. De-identified sample data was used to conduct this study.
: Not Applicable.
: Dr. Hakonarson and CHOP own stock in Aevi Genomic Medicine (unrelated to this manuscript); otherwise, none declared.